Ackerman Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Ackerman Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Aug 14, 2020	SELL	$62.63 - $80.22 $375,780 - $481,320	-6,000 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$61.62 - $67.78 $154,050 - $169,450	2,500 Added 71.43%	6,000 $390,000
Q3 2019 Oct 09, 2019	BUY	$62.51 - $69.0 $218,785 - $241,500	3,500 New	3,500 $222,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ackerman Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ackerman Capital Advisors, LLC with notifications on news.